Knockdown of p21-activated kinase 6 inhibits prostate cancer growth and enhances chemosensitivity to docetaxel
about
Group II p21-activated kinases as therapeutic targets in gastrointestinal cancerUpregulation of p21-activated Kinase 6 in rat brain cortex after traumatic brain injuryPAK6 increase chemoresistance and is a prognostic marker for stage II and III colon cancer patients undergoing 5-FU based chemotherapyDownregulation of microRNA-23a suppresses prostate cancer metastasis by targeting the PAK6-LIMK1 signaling pathwayMicroRNA‑328 directly targets p21‑activated protein kinase 6 inhibiting prostate cancer proliferation and enhancing docetaxel sensitivityPAK6 targets to cell-cell adhesions through its N-terminus in a Cdc42-dependent manner to drive epithelial colony escapePAK as a therapeutic target in gastric cancerp21-Activated kinase 6 (PAK6) inhibits prostate cancer growth via phosphorylation of androgen receptor and tumorigenic E3 ligase murine double minute-2 (Mdm2)P21 activated kinase-1 (Pak1) promotes prostate tumor growth and microinvasion via inhibition of transforming growth factor β expression and enhanced matrix metalloproteinase 9 secretionA PAK6-IQGAP1 complex promotes disassembly of cell-cell adhesionsDiversity of antigen-specific responses induced in vivo with CTLA-4 blockade in prostate cancer patients.Prostate cancer research in China.Chronic exposure to cigarette smoke leads to activation of p21 (RAC1)-activated kinase 6 (PAK6) in non-small cell lung cancer cells.Potential use of RNA interference in cancer therapy.Structure, biochemistry, and biology of PAK kinases.Diabetes causes multiple genetic alterations and downregulates expression of DNA repair genes in the prostate.Prognostic and Predictive Value of p21-activated Kinase 6 Associated Support Vector Machine Classifier in Gastric Cancer Treated by 5-fluorouracil/Oxaliplatin Chemotherapy.Cross-talk of alpha tocopherol-associated protein and JNK controls the oxidative stress-induced apoptosis in prostate cancer cells.
P2860
Q26774494-9FE21768-7790-4E64-8545-F017CF8AA456Q28236692-C84E8339-9222-44DD-92C0-AE2E7309E440Q28252178-57416221-829B-415D-975B-E6D5343BF50FQ28257722-2918CE05-8469-4751-846F-2F8820BDF949Q28268506-C4BD8AAB-5039-4B8A-ACC9-D806E690D9D3Q28270125-A480E330-FA91-42EF-B1A7-3CB6B3114B4CQ28272877-01AD8958-5643-4665-A234-C1788FB0EE37Q28278797-A103876A-B466-4981-80A5-949E2AB70CD1Q28281866-1EC13F9A-039B-4786-8DC9-171EF50A7DA2Q28304367-4F6B7F29-BE51-4D1A-80C5-8915AAC8E831Q36252546-C3F193D8-24DB-4EA6-8FA1-E3B66B552D90Q37085423-720B8D3A-56F8-4AC3-8625-719BCAFD255AQ37641586-F4C7CB13-56E6-4EE1-AEE4-D9A56EBE9F12Q37780603-2A90B518-A80E-428B-BD49-8E15982A1FF2Q38779105-8B987D20-9A01-4AF7-9EF2-55DF48345C99Q39529518-14746828-7198-44D8-B34D-968478CA3F35Q40143892-AC2974BD-395C-4C55-8B38-3C0D1AE6A984Q52631436-048C772C-556C-4FB6-80D6-2E773E9F9029
P2860
Knockdown of p21-activated kinase 6 inhibits prostate cancer growth and enhances chemosensitivity to docetaxel
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Knockdown of p21-activated kin ...... chemosensitivity to docetaxel
@ast
Knockdown of p21-activated kin ...... chemosensitivity to docetaxel
@en
Knockdown of p21-activated kin ...... chemosensitivity to docetaxel
@nl
type
label
Knockdown of p21-activated kin ...... chemosensitivity to docetaxel
@ast
Knockdown of p21-activated kin ...... chemosensitivity to docetaxel
@en
Knockdown of p21-activated kin ...... chemosensitivity to docetaxel
@nl
prefLabel
Knockdown of p21-activated kin ...... chemosensitivity to docetaxel
@ast
Knockdown of p21-activated kin ...... chemosensitivity to docetaxel
@en
Knockdown of p21-activated kin ...... chemosensitivity to docetaxel
@nl
P2093
P1433
P1476
Knockdown of p21-activated kin ...... chemosensitivity to docetaxel
@en
P2093
Bin Ouyang
Jieying Wu
Qipeng Sun
Xiaojuan Li
Xiaoxu Yuan
Xingqiao Wen
P304
P356
10.1016/J.UROLOGY.2008.09.041
P407
P577
2009-06-01T00:00:00Z